Furthermore, in patients with a history of anti-CDK4/6-induced liver injury, exposure to another CDK4/6 inhibitor does not seem to be associated with hepatitis relapse, suggesting the absence of cross-direct hepatotoxicity or the development of an adaptation to this drug family. Here, CDK4 is linked to Hepatitis.